Corneal Blindness

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-11-04
Clinical Trial Update: Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS) [Phase 1, Phase 2]
The clinical trial evaluating infliximab to improve retention of the Boston Keratoprosthesis in patients after Stevens-Johnson Syndrome/Toxi…